News from the ESC Congress: Anti-Inflammatory Drug Cuts CV Events / Rivaroxaban+Aspirin / More... (FREE)

By the Editors NEJM Journal Watch is covering the European Society of Cardiology Congress in Barcelona this week. Here are highlights from some of the presented trials:CANTOS: Canakinumab, an anti-inflammatory drug that inhibits interleukin-1 beta, showed modest benefits in treating atherosclerotic disease, but there were …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news